Skip to content

Nutrition to relieve IBS constipation

Nutrition to relieve IBS constipation - NUTRIC study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON50958
Enrollment
180
Registered
2021-02-24
Start date
2021-03-18
Completion date
Unknown
Last updated
2024-04-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Irritable Bowel Syndrome

Interventions

A 4 week run-in period will be followed by a 4-week intervention period with three parallel arms: 1) prebiotic supplement (Inavea pure acacia), 2) probiotic supplement (B. lactis), and 3) Placebo su

Sponsors

Wageningen Universiteit
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: * IBS patients that meet the Rome IV criteria + additional criteria specific for the constipation-predominant subtype. * Male and female adults, aged 18-70 years. * Have a Body Mass Index (BMI) between 18.5 and 30 kg/m2 (self-reported). * Willing to keep a stable dietary pattern throughout the study. * Having a smartphone to fill out the daily questionnaires

Exclusion criteria

Exclusion criteria: * Having a disease that may interfere with the outcomes of this study, such as a known autonomic disorder, inflammatory bowel disease, coeliac disease, cancer, dialysis patients, chronic kidney failure, depression or hypothyroidism. * History of intestinal surgery (excluding appendectomy or cholecystectomy) or endometriosis. * Use of medication that can interfere with the study outcomes, including antidepressants (allowed when it is not subscribed for mental depression), codeine, and antibiotics, as judged by the medical supervisor MD Ben Witteman. * Use of prescribed laxatives. Over-the-counter laxatives are allowed, but intake should be either stopped before the start of the study or kept stable during the complete study period. * Use of prebiotics and/or probiotics (should be stopped 4 weeks before the start of the study) and infrequent use of other (fiber) supplements dedicated to bowel function improvements. Some supplements are allowed, but intake should be kept stable during the whole study period (Supplements will be judged by the medical supervisor MD Ben Witteman). * If applicable: currently pregnant or breastfeeding, or intending to become pregnant during the study, as this can affect stool pattern and wellbeing. * Participation in another clinical trial at the same time. * Student or employee working at Food, Health and Consumer Research from Food and Biobased Research, or Department of Human Nutrition & Health, Wageningen University. * Alcohol intake * 2 (women) or * 4 (men) glasses of alcoholic beverages per day. * Abuse of illicit drugs, soft drugs, and nitrous oxide. * Smoking

Design outcomes

Primary

MeasureTime frame
The primary study parameter is stool pattern: stool frequency, stool consistency and stool volume.

Secondary

MeasureTime frame
The secondary study parameters are gastrointestinal complaints, Quality of Life, and HADS.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)